HCV ADVOCATE WEEKLY NEWS REVIEW

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW

Week Ending: February 20, 2010

This Issue:

Certain Syringes More Likely to Spread Hepatitis C Virus among Drug Users Scioto County Ranks First in Hepatitis C Cases Transfusion Victim Fights for Pay-Out Survey of HBsAg-Positive Pregnant Women and Their Infants Regarding Measures to Prevent Maternal-Infantile Transmission Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication SHEA Releases Guidelines on Management of Healthcare Workers Infected with Hepatitis, HIV Group Advocates Hepatitis C Education Bill Would Ease Ban on Selling Syringes Congress Considers Banning Medical Experiments on Chimpanzees Pharmasset Announces Complete Enrollment of RG7128 Phase 2b Clinical Study Dynavax Receives Canadian Approval to Conduct Phase 3 Trials of HEPLISAVâ„¢ FDA Warns of Maalox Mix-up Danger Transplants Can Give Cirrhosis Patients a Brand-New Start, but Supply of Liver Donors Is Short Guitar Legend Reveals Virus Shock The Lack of Needles and the Damage Done Clinic's Patients Warned of Hepatitis C Outbreak Drug Diversion Needs More Compliance Attention; Hospital Technician Is Heading to Prison 'Right to Know' Bill Would Impact Inmates with Diseases

http://www.hcvadvocate.org/news/newsRev/2010/NewsRev-349.html